Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000861177-25-000007
Filing Date
2025-07-17
Accepted
2025-07-17 16:06:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6668
  Complete submission text file 0000861177-25-000007.txt   8751
Mailing Address ONE NORTH WACKER DRIVE CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE CHICAGO IL 60606 60606
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (Filed by) CIK: 0000861177 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 0000

Mailing Address WAGISTRASSE 14 Z?RICH-SCHLIEREN V8 8952
Business Address WAGISTRASSE 14 Z?RICH-SCHLIEREN V8 8952 41 44 755 77 00
MOLECULAR PARTNERS AG (Subject) CIK: 0001745114 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92857 | Film No.: 251130729
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)